RG
BSX icon

Redmile Group’s Boston Scientific BSX Stock Holding History

Redmile Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-85,301
Closed -$9.16M – 42
2025
Q2 		$9.16M Sell
85,301
-107,982
-56% -$10.9M 0.98% 24
2025
Q1 		$19.5M Sell
193,283
-119,400
-38% -$12M 1.84% 17
2024
Q4 		$27.9M Sell
312,683
-18,190
-5% -$1.6M 1.95% 19
2024
Q3 		$27.7M Sell
330,873
-59,380
-15% -$4.68M 1.63% 27
2024
Q2 		$30.1M Sell
390,253
-170,673
-30% -$12.5M 1.82% 23
2024
Q1 		$38.4M Sell
560,926
-132,274
-19% -$8.5M 1.41% 27
2023
Q4 		$40.1M Sell
693,200
-81,000
-10% -$4.32M 1.43% 20
2023
Q3 		$40.9M Buy
774,200
+383,022
+98% +$20.1M 1.94% 14
2023
Q2 		$21.2M Buy
391,178
+219,398
+128% +$11.5M 0.81% 36
2023
Q1 		$8.59M Buy
+171,780
New +$8.1M 0.37% 54
2020
Q4 		– Sell
-1,422,049
Closed -$54.3M – 88
2020
Q3 		$54.3M Buy
1,422,049
+524,694
+58% +$20.2M 1% 35
2020
Q2 		$31.5M Buy
+897,355
New +$32.3M 0.58% 45
2020
Q1 		– Sell
-1,631,200
Closed -$73.8M – 71
2019
Q4 		$73.8M Buy
+1,631,200
New +$68.3M 1.76% 20
2017
Q4 		– Sell
-603,493
Closed -$17.6M – 73
2017
Q3 		$17.6M Sell
603,493
-491,490
-45% -$13.6M 0.87% 35
2017
Q2 		$30.4M Sell
1,094,983
-105,116
-9% -$2.79M 1.85% 20
2017
Q1 		$29.8M Buy
1,200,099
+740,594
+161% +$18M 1.94% 18
2016
Q4 		$9.94M Sell
459,505
-613,133
-57% -$13.4M 0.86% 31
2016
Q3 		$25.5M Sell
1,072,638
-157,682
-13% -$3.76M 2.03% 17
2016
Q2 		$28.8M Sell
1,230,320
-102,200
-8% -$2.21M 2.75% 13
2016
Q1 		$25.1M Sell
1,332,520
-918,500
-41% -$16.1M 2.57% 15
2015
Q4 		$41.5M Buy
+2,251,020
New +$40.3M 3.11% 13
2014
Q3 		– Sell
-10,000
Closed -$128K – 57
2014
Q2 		$128K Buy
+10,000
New +$130K 0.02% 46

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Redmile Group's BSX Position: Q3 2025 in Review

Redmile Group sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 85,301 shares — an estimated $9.16M sold.

Redmile Group first reported a position in BSX in Q2 2014 and held it in 22 quarters. The position peaked at $73.8M in Q4 2019. 1,715 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Redmile Group reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Redmile Group sold 85,301 Boston Scientific shares in Q3 2025, an estimated $9.16M.
  • Redmile Group first reported a position in Boston Scientific in Q2 2014 and held it in 22 quarters.
  • Redmile Group's Boston Scientific position peaked at $73.8M in Q4 2019.
  • 1,715 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Redmile Group's 13F filing for Q3 2025, filed 14 Nov 2025.